European shares inch higher; AstraZeneca tumbles on halting vaccine trials

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

Sept 9 (Reuters) - European shares steadied on Wednesday after hefty declines in the previous session, although sentiment was rattled by AstraZeneca suspending global trials for its COVID-19 vaccine.

AstraZeneca Plc shares slipped 1.3% as it also paused large late-stage trials of its experimental vaccine due to an unexplained illness in a study participant.

The pan-European STOXX 600 index edged 0.1% higher at 0710 GMT, with travel and leisure stocks among the biggest decliners in early trading. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Bernard Orr)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.